Overview
- The authors published peer-reviewed preclinical results in Nature Biomedical Engineering on Tuesday, June 2, 2026, describing a postage-stamp-sized ultrasound sticker and a pocket electronics unit as a working prototype.
- In lab tests on engineered human-derived cardiac cells, sonogenetic sensitization caused specific ion channels to open when hit by ultrasound, letting calcium into cells and syncing their beats to the acoustic pulses.
- In acute rat experiments the sticker noninvasively corrected slow or irregular heart rhythms and restored regular contractions after the animals received the research team’s gene-sensitizing treatment.
- The proposed clinical path would pair a one-time, gene-therapy–style injection to sensitize a patient’s heart cells with a wearable sticker that could be miniaturized and integrated with ultrasound imaging for closed-loop monitoring and pacing.
- Researchers emphasize the work is preclinical and must clear challenges before human use, including device miniaturization, long-term safety testing, durability of genetic sensitization, and regulatory and ethical review.